(Q39993976)

16 September 2017

Mutational analysis of the BRAF gene in human tumor cells (English)

1 reference

16 September 2017

1 reference

6

Kiyo Torii

1 reference

16 September 2017

7

Sadamu Noda

1 reference

16 September 2017

2

Eisaku Toji

1 reference

16 September 2017

4

Shinji Izuma

1 reference

16 September 2017

Masatsugu Ueda

1

1 reference

16 September 2017

Osamu Nunobiki

series ordinal

3

1 reference

16 September 2017

Yoshiaki Okamoto

series ordinal

5

1 reference

16 September 2017

language of work or name

1 reference

1 May 2008

1 reference

16 September 2017

1 reference

16 September 2017

21

1 reference

16 September 2017

13-17

1 reference

16 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1111/j.1749-0774.2008.00046.x

16 September 2017

0 references

cites work

The Raf/MEK/ERK pathway: new concepts of activation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00046.X

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00046.X

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00046.X

Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00046.X

New insight into BRAF mutations in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00046.X

RAF/RAS oncogenes and mismatch-repair status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00046.X

Missense mutations of the BRAF gene in human lung adenocarcinoma.

21 January 2018

1 reference

12 December 2020

BRAF and RAS mutations in human lung cancer and melanoma

1 reference

12 December 2020

Germ line and somatic mutations of BRAF V599E in ovarian carcinoma

1 reference

12 December 2020

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma

1 reference

12 December 2020

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

12 December 2020

The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma.

1 reference

12 December 2020

BRAF mutations in papillary thyroid carcinoma

1 reference

12 December 2020

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

12 December 2020

10.1111/J.1749-0774.2008.00046.X

Identifiers

DOI

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference